Common and specific genes in ovarian clear cell carcinoma and serous carcinoma by gene expression analysis

被引:2
|
作者
Cao, Wenjiao [1 ]
Wang, Lihua [1 ]
机构
[1] Shanghai Jiao Tong Univ, Int Peace Matern & Child Hlth Hosp, Sch Med, China Welf Inst IPMCH, Shanghai 200030, Peoples R China
关键词
Ovarian clear cell carcinoma (CCC); ovarian serous carcinoma (SC); histological subtype; specific genes; gene expression; 2ND PRIMARY TUMORS; POOR-PROGNOSIS; CANCER; PROGRESSION; PROFILES; SURVIVAL; EVENT;
D O I
10.21037/tcr.2018.11.12
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Gene expression profiles differences of clear cell carcinoma (CCC) and serous carcinoma (SC) have been documented, however, these studies usually miss the specific genes changed only in SC or CCC. This study analyzes gene expression profiles of the two histological types and normal ovarian surface epithelium to determine the common and specific genes in these tumors. Methods: The gene expression profiles GSE29450 and GSE36668 were downloaded and analyzed, followed by differentially expressed genes (DEGs) analysis between ovarian cancer and normal samples. Overlap analysis was performed to identify common and specific DEGs in SC and CCC, and then these DEGs were functionally enriched. Subsequently, the protein-protein interaction (PPI) network was constructed on these DEGs and Oncomine analysis was down on select genes. Results: A set of 1,265 DEGs were common to comparisons of each of the two histologic subtypes with normal ovarian surface epithelium, such as ESPL1 and CDC25C, and they were mainly enriched in functions and pathways associated with "chromosome segregation". In addition, 2,971 specific DEGs were identified in the development of ovarian CCC including ribosomes protein genes and other key nodes. Whereas a list of 4,181 DEGs were in SC progression, such as KIT and SYK. Conclusions: The common genes appearing on each ovarian carcinoma subtype's comparison with normal ovarian surface epithelium may benefit to shed light on the common part of molecular mechanisms for ovarian carcinomas pathogenesis. Whereas the specific genes may provide unique targeted therapy for each histological subtype.
引用
收藏
页码:1501 / 1509
页数:9
相关论文
共 50 条
  • [1] Differentiation of ovarian serous carcinoma from ovarian clear cell carcinoma using a 10-gene signature selected by comprehensive gene expression analysis
    Nomura, Shinji
    Watanabe, Takafumi
    Honma, Reiko
    Matsukura, Susumu
    Ito, Emi
    Imai, Jun-ichi
    Kiko, Yuichiro
    Suzuki, Osamu
    Hashimoto, Yuko
    Kojima, Manabu
    Furukawa, Shigenori
    Soeda, Shu
    Watanabe, Shinya
    Fujimori, Keiya
    FUKUSHIMA JOURNAL OF MEDICAL SCIENCE, 2024, 70 (02) : 65 - 73
  • [2] Distinct gene expression profiles associated with clinical outcomes in patients with ovarian clear cell carcinoma and high-grade serous ovarian carcinoma
    Zhou, Huimei
    Liu, Qian
    Shi, Xiaohua
    Liu, Yue
    Cao, Dongyan
    Yang, Jiaxin
    JOURNAL OF OVARIAN RESEARCH, 2020, 13 (01)
  • [3] Distinct gene expression profiles associated with clinical outcomes in patients with ovarian clear cell carcinoma and high-grade serous ovarian carcinoma
    Huimei Zhou
    Qian Liu
    Xiaohua Shi
    Yue Liu
    Dongyan Cao
    Jiaxin Yang
    Journal of Ovarian Research, 13
  • [4] Cytokine gene expression signature in ovarian clear cell carcinoma
    Yanaihara, Nozomu
    Anglesio, Michael S.
    Ochiai, Kazunori
    Hirata, Yukihiro
    Saito, Misato
    Nagata, Chie
    Iida, Yasushi
    Takakura, Satoshi
    Yamada, Kyosuke
    Tanaka, Tadao
    Okamoto, Aikou
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2012, 41 (03) : 1094 - 1100
  • [5] Gene expression profile in ovarian clear cell carcinoma cells
    Chung, TKH
    Cheung, TH
    Chan, LKY
    Wong, YF
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 335 - 335
  • [6] Ovarian Clear Cell Carcinoma and Serous Carcinoma: Immunohistochemical Profile and Correlation with Chemoresistance
    Kwak, H. A.
    Fadare, O.
    Quick, C. M.
    Lengvel, E.
    Montag, A.
    Gwin, K.
    LABORATORY INVESTIGATION, 2014, 94 : 291A - 291A
  • [7] Ovarian Clear Cell Carcinoma and Serous Carcinoma: Immunohistochemical Profile and Correlation with Chemoresistance
    Kwak, H. A.
    Fadare, O.
    Quick, C. M.
    Lengyel, E.
    Montag, A.
    Gwin, K.
    MODERN PATHOLOGY, 2014, 27 : 291A - 291A
  • [8] Differential expression of estrogen receptor subtypes in ovarian high-grade serous carcinoma and clear cell carcinoma
    Osaku, Daiken
    Oishi, Tetsuro
    Kawamura, Naoshi
    Iida, Yuki
    Komatsu, Hiroaki
    Kudoh, Akiko
    Chikumi, Jun
    Sato, Shinya
    Harada, Tasuku
    REPRODUCTIVE MEDICINE AND BIOLOGY, 2021, 20 (04) : 467 - 476
  • [9] Expression of podoplanin in ovarian clear cell carcinoma
    Kotarski, Jozef
    Marzec-Kotarska, Barbara
    Szumilo, Justyna
    Klepacz, Robert
    Cybulski, Marek
    Sobstyl, Malgorzata
    Bednarek, Wieslawa
    GINEKOLOGIA POLSKA, 2011, 82 (05) : 350 - 353
  • [10] Profile of differentially expressed miRNAs in high-grade serous carcinoma and clear cell ovarian carcinoma, and the expression of miR-510 in ovarian carcinoma
    Zhang, Xinchen
    Guo, Gordon
    Wang, Guang
    Zhao, Jinyao
    Wang, Bo
    Yu, Xiaotang
    Ding, Yanfang
    MOLECULAR MEDICINE REPORTS, 2015, 12 (06) : 8021 - 8031